Trade Zoetis - ZTS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.18 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023401% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001179% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 146.23 |
| Open | 146.85 |
| 1-Year Change | -3.98% |
| Day's Range | 146.85 - 149.69 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 17, 2025 | 148.53 | 1.43 | 0.97% | 147.10 | 149.84 | 146.00 |
| Apr 16, 2025 | 146.23 | -2.24 | -1.51% | 148.47 | 149.87 | 145.59 |
| Apr 15, 2025 | 149.12 | -1.83 | -1.21% | 150.95 | 151.20 | 148.16 |
| Apr 14, 2025 | 150.68 | -0.22 | -0.15% | 150.90 | 151.52 | 147.29 |
| Apr 11, 2025 | 149.36 | 3.15 | 2.15% | 146.21 | 149.61 | 143.55 |
| Apr 10, 2025 | 146.39 | -4.51 | -2.99% | 150.90 | 151.95 | 141.99 |
| Apr 9, 2025 | 152.82 | 12.56 | 8.95% | 140.26 | 154.06 | 139.13 |
| Apr 8, 2025 | 144.31 | -8.00 | -5.25% | 152.31 | 152.31 | 142.33 |
| Apr 7, 2025 | 146.59 | -0.36 | -0.24% | 146.95 | 152.57 | 143.74 |
| Apr 4, 2025 | 151.51 | -4.69 | -3.00% | 156.20 | 156.53 | 150.42 |
| Apr 3, 2025 | 159.10 | -3.99 | -2.45% | 163.09 | 166.00 | 158.55 |
| Apr 2, 2025 | 162.99 | 2.09 | 1.30% | 160.90 | 163.57 | 160.65 |
| Apr 1, 2025 | 161.38 | -2.44 | -1.49% | 163.82 | 165.49 | 161.09 |
| Mar 31, 2025 | 163.96 | 1.23 | 0.76% | 162.73 | 164.80 | 161.29 |
| Mar 28, 2025 | 162.61 | -0.97 | -0.59% | 163.58 | 165.16 | 162.61 |
| Mar 27, 2025 | 164.52 | 1.75 | 1.08% | 162.77 | 165.32 | 161.95 |
| Mar 26, 2025 | 162.59 | 1.64 | 1.02% | 160.95 | 163.06 | 160.48 |
| Mar 25, 2025 | 161.00 | -1.19 | -0.73% | 162.19 | 164.06 | 160.16 |
| Mar 24, 2025 | 162.97 | 2.08 | 1.29% | 160.89 | 164.90 | 160.89 |
| Mar 21, 2025 | 162.56 | 1.11 | 0.69% | 161.45 | 162.88 | 160.12 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Zoetis Company profile
About Zoetis Inc
Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company operate its business through two segments: the United States and International. Within each of these operating segments, it offers a product portfolio for both companion animal and livestock customers. The Company market its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America, and its products are sold in more than 100 countries.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Zoetis Inc revenues increased 16% to $7.78B. Net income increased 24% to $2.04B. Revenues reflect International segment increase of 20% to $3.65B, US segment increase of 14% to $4.04B, United States segment increase of 14% to $4.04B, Other emerging markets segment increase of 19% to $778M. Net income benefited from Interest Expense -Gross decrease of 2% to $244M (expense).
Equity composition
Class A Common Stock $.01 Par, 2/13, 5M auth., 86,100,000 issd. Insiders own less than 1%. Class B Common Stock $.01 Par, 1B auth., 413,900,000 issd.
| Industry: | Veterinary Drugs |
10 Sylvan Way
PARSIPPANY
NEW JERSEY 07054
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com